Regulatory status : IV infusions of products containing NAD+ are not approved by the Therapeutic Goods Administration (TGA) because they have not been assessed for safety, quality or efficacy
BPC-157 has been shown in numerous studies to upregulate Vascular Endothelial Growth Factor (VEGF), a key signaling protein that stimulates the formation of new blood vessels
Lack of FDA approval and standardized clinical data limits confirmed use in medical practice despite promising preclinical findings
Front Aging Neurosci 14:1105019 Choi YJ et al (2021) Gastrectomy, vitamin B12 supplementation and the risk of Parkinsons disease: a nationwide cohort study
Therapeutic Applications and Considerations BPC 157 is explored for several recovery-related use cases, including joint support, soft-tissue healing, gastrointestinal irritation, and mucosal repair
Additionally, B12 injections can help to suppress the appetite, leading to fewer cravings and less overall food intake
